Jan 15, 2026 02:48
BHVN - Biohaven Ltd.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 9.5 0.25 (2.63%) | -0.01 (-0.1%) | 0.02 (0.21%) | -0.2 (-2.01%) | 0.22 (2.32%) | 0.11 (1.14%) | 0.07 (0.73%) | 0.14 (1.46%) |
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -1.94
- Diluted EPS:
- -1.94
- Basic P/E:
- -5.0258
- Diluted P/E:
- -5.0258
- RSI(14) 1m:
- 31.41
- VWAP:
- 9.75
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Dec 26, 2025 14:26
Dec 02, 2025 18:00
Nov 19, 2025 22:15
Oct 15, 2025 11:00
Sep 29, 2025 17:35
Sep 12, 2025 14:00
Sep 11, 2025 20:00
Sep 11, 2025 16:43
Sep 10, 2025 14:00